AZIN1 and colorectal cancer: Many studies suggest that RNA editing at the S/G site of AZIN1 is increased in multiple cancers, such as hepatocellular carcinoma, esophageal squamous cell carcinoma, gastric cancer, and colorectal cancer (55, 59, 65, 66).